Home  »  Finance   »  Tonix Pharmaceuticals Holding Corp. (TNXP) Looks R...

Tonix Pharmaceuticals Holding Corp. (TNXP) Looks Ready for Growth Despite -94.29% Change This Year

Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) is -94.29% lower on its value in year-to-date trading and has touched a low of $0.69 and a high of $20.32 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The TNXP stock was last observed hovering at around $0.70 in the last trading session, with the day’s loss setting it -0.05% off its average median price target of $10.00 for the next 12 months. It is also 93.5% off the consensus price target high of $10.00 offered by 1 analysts, but current levels are 93.5% higher than the price target low of $10.00 for the same period.

Currently trading at $0.65, the stock is -35.23% and -49.87% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 2.95 million and changing -7.23% at the moment leaves the stock -87.51% off its SMA200. TNXP registered -96.53% loss for a year compared to 6-month loss of -91.57%.

Top 5 Cheap Stocks to Own Right Now

While finding safe stocks with the potential for monster gains isn't always easy, we've found a few that could pay out well. In fact, within our report, "Top 5 Cheap Stock to Own Right Now", we have identified five stocks we believe could appreciate the most even if you just have $1,000 to invest.

Sign up here to get your free report now. .


The stock witnessed a -49.69% gain in the last 1 month and extending the period to 3 months gives it a -64.46%, and is -29.21% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 9.30% over the week and 7.99% over the month.

Distance from 52-week low is -4.87% and -96.78% from its 52-week high.

Tonix Pharmaceuticals Holding Corp. (TNXP) Analyst Forecasts

Analyst recommendations provided by FactSet shows that the consensus forecast for Tonix Pharmaceuticals Holding Corp. (TNXP) is a “Buy”. 1 analysts offering their recommendations for the stock have an average rating of 2.00, where 0 rate it as a Hold and 0 think it is a “Overweight”. 1 of the analysts rate the stock as a “Buy”. 0 analysts have rated the stock as a Sell or Underperform.

Tonix Pharmaceuticals Holding Corp. is expected to release its quarterly report on 11/11/2022.The EPS is expected to grow by 53.60% this year.

Tonix Pharmaceuticals Holding Corp. (TNXP) Top Institutional Holders

The shares outstanding are 44.17M, and float is at 44.16M with Short Float at 5.43%.

Tonix Pharmaceuticals Holding Corp. (TNXP) Insider Activity

A total of 0 insider transactions have happened at Tonix Pharmaceuticals Holding Corp. (TNXP) in the last six months, with sales accounting for 0 and purchases happening 0 times. The most recent transaction is an insider purchase by LEDERMAN SETH,the company’sChief Executive Officer. SEC filings show that LEDERMAN SETH bought 20,000 shares of the company’s common stock on Jun 29 at a price of $1.71 per share for a total of $34200.0. Following the purchase, the insider now owns 24235.0 shares.

Tonix Pharmaceuticals Holding Corp. disclosed in a document filed with the SEC on Mar 25 that LEDERMAN SETH (Chief Executive Officer) bought a total of 100,000 shares of the company’s common stock. The trade occurred on Mar 25 and was made at $0.24 per share for $24500.0. Following the transaction, the insider now directly holds 0.11 million shares of the TNXP stock.

Still, SEC filings show that on Sep 28, LEDERMAN SETH (Chief Executive Officer) acquired 12,000 shares at an average price of $0.61 for $7320.0. The insider now directly holds 12,177 shares of Tonix Pharmaceuticals Holding Corp. (TNXP).

Most Popular

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Related Posts




The 5 Best Inflation Stocks for 2022

100% free. stop anytime no spam

Get our free report on the stocks that we recommend for investors who want to protect their portfolios from inflation.